No Covaxin doses left for 45-plus, healthcare workers after May 24: AAP MLA

There will be no Covaxin doses left for those aged above 45, frontline and healthcare workers in Delhi after Monday, with no clarity on the supply of next installment from Centre, says AAP MLA Atishi

No Covaxin doses left for 45-plus, healthcare workers after May 24: AAP MLA
Press Trust of India New Delhi
2 min read Last Updated : May 23 2021 | 8:15 PM IST

There will be no Covaxin doses left for those aged above 45, frontline and healthcare workers in Delhi after Monday, with no clarity on the supply of the next installment from the Centre, AAP MLA Atishi said on Sunday.

She said the national capital has so far received 45.94 lakh vaccine doses for healthcare workers, frontline staff and those aged above 45, of which, 43.79 lakh have been administered to the beneficiaries.

Delhi has only 25,000 Covaxin doses left for this (above 45 years) category. Though the last installment received from the Centre is being used for second doses, there will be no doses left after Monday, she said.

The AAP leader rued that there has been no clarity on the supply of the next installment of Covaxin for this category, though the central government had promised to provide more doses in June.

She said the city has received 8.17 lakh vaccine doses for the 18-44 age group so far, of which, 8.07 lakh doses had been utilised by Sunday morning.

Vaccination centres administering Covaxin have already been shut. Similarly, Covishield inoculation centres will have to be closed from Monday, she said.

Atishi noted that 64,214 people received the vaccine jabs on May 22.

A total of 50.85 lakh doses have been administered to the beneficiaries in Delhi since the nationwide inoculation drive began on January 16. Around 11.51 lakh people have got both the doses, she added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusAtishi MarlenaCoronavirus VaccineCoronavirus Tests

First Published: May 23 2021 | 8:07 PM IST

Next Story